Abstract
Based on the research by the Institute of Psychology of the Russian Academy of Sciences, the level of anxiety and depression is growing across the country. The greatest blow falls on young people aged 18–24, with about 77 % noting depressive symptoms in themselves. Zurab Kekelidze, the director general of the Serbsky Center, responsible for providing the World Health Organization (WHO) with data on people with depression, revealed that about 8 million people in Russia suffer from this disease. That is why it is essential for a practitioner to pay attention to the effectiveness of the chosen drug therapy, as well as to take into account adverse reactions. The purpose of the review. This article provides an update on the clinical pharmacology, mechanisms of action, and safety of antidepressants, antipsychotics, and the results of their combination in the treatment of depression. We identified potentially relevant studies by searching the electronic databases MEDLINE, SCOPUS, PubMed, Google Scholar, and the Cochrane Database of Systematic Reviews for the last 5 years up to December 2022, using the terms: depression, mental disorders, therapy, safety, efficacy, adverse effects. Results. Recent studies have shown the efficacy and good tolerability of antidepressant and antipsychotic therapy in the treatment of depression.
Publisher
PANORAMA Publishing House
Subject
General Earth and Planetary Sciences,General Environmental Science,General Medicine,General Earth and Planetary Sciences,General Environmental Science,General Medicine,General Medicine,General Medicine,General Medicine,Rehabilitation,Physical Therapy, Sports Therapy and Rehabilitation,General Medicine,Geology,Ocean Engineering,Water Science and Technology,General Medicine
Reference20 articles.
1. 1. Arana D., Rozenbaum D. Farmakoterapiia psikhicheskikh rasstroistv [Pharmacotherapy of mental disorders]. - M., 2004. - 416 p. (In Russ.)
2. 2. Avrutskii G. Ia. Neotlozhnaia pomoshch v psikhiatrii [Emergency care in psychiatry]. - M., 1979. (In Russ.)
3. 3. Krasnov V. N. Zakonomernosti depressii, klinicheskie, patogeneticheskie i terapevticheskie aspekty [Patterns of depression, clinical, pathogenetic and therapeutic aspects]. Depressii i komorbidnye rasstroistva [Depression and Comorbid Disorders]. М. 1997; 80-98. (In Russ.)
4. 4. Nelson J. C., Mankoski R., Baker R. A., Carlson B. X., Eudicone J. M., Rikalov A., Tran Q. V., Berman R. M. Effects of aripiprazole adjunctive to standard antidepressant treatment on the core symptoms of depression: a post hoc, pooled analysis of two large, placebo - controlled studies. J Affect Disord 2010; 120: 1-3: 133-140.
5. 5. Nelson J. C., Papakostas G. I. Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controled randomized tials. Am J Psychiatry 2009; 166: 9: 980-991.